Dr. Jason W. Schultz, DMD, MD

Dr. Schultz practices at Presbyterian Medical Group in Albuquerque, New Mexico.

Dr. Schultz's NPI, 1952664039, was assigned on June 22, 2012. Dr. Schultz graduated from Harvard Medical School in 2016. Dr. Schultz holds New Mexico license MD2019-0687.

Dr. Schultz's primary practice is Presbyterian Medical Group, at 6100 Pan American NE Fwy, Albuquerque, NM 87109 in Bernalillo County. The practice phone is (505) 823-8556.

Dr. Schultz's primary practice is Presbyterian Medical Group in Albuquerque, New Mexico. Dr. Schultz is also affiliated with Presbyterian Hospital. The medical group on file is Presbyterian Medical Group. Dmand AI also links Dr. Schultz to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schultz practices, 2 sites in all. Vendor and product names are available with a free account.

Oral and maxillofacial surgery is Dr. Schultz's primary specialty in the NPI Registry, under taxonomy code 204E00000X. Dr. Schultz is licensed in New Mexico.

CMS data shows 161 Medicare services from Dr. Schultz across 5 procedure codes in 2024, for 109 Medicare patients. Medicare paid $10,144 for them. Every service was in an office.

CMS counts 109 Medicare patients who saw Dr. Schultz in 2024. The largest group is 65 to 74, with 40 patients. 55% of them have high cholesterol, and 50% have high blood pressure. 29% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schultz's median patient age at 49, with 56% women.

In 2024, Dr. Schultz wrote 571 Medicare Part D claims for 181 patients. 100% of them were for generic drugs. CMS names the drug for 539 of them, across 9 drugs with 11 or more claims each, at $4,055 in total drug cost. In 2023, CMS named 465 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Schultz for performance year 2024, reported as part of a group. Dr. Schultz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 165 general payments to Dr. Schultz from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 45% of the total. Stryker Corporation paid the most, $5,734.

Dr. Schultz graduated from Harvard Medical School in 2016.